Wegovy, por ejemplo, tiene un precio de 1,349 dlares para un suministro de cuatro semanas, aunque algunos planes de seguros lo cubren
H., Smith, E
Recent industry developments underscore strong patient demand and an expanding range of treatment options aimed at improving access and outcomes.'' With nearly 100 million adults living with diabetes and rising obesity-linked conditions, India's anti-obesity market, valued at just over Rs 1,000 crore (MAT Nov), has grown nearly 10-fold in five years
revealed that GLP-1RA therapy did not reduce fracture incidence in type 2 diabetic patients
A randomized, multicenter, evaluator-blind study to evaluate the safety and effectiveness of VYC-12L treatment for skin quality improvements
Fake and counterfeit GLP-1s have hit the market